U.S. markets closed

Fresenius Medical Care AG & Co. KGaA (FMS)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
14.22+0.18 (+1.28%)
At close: 04:00PM EDT
14.56 +0.34 (+2.39%)
After hours: 05:38PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close14.04
Bid14.15 x 2200
Ask14.69 x 1300
Day's Range13.70 - 14.25
52 Week Range13.69 - 36.08
Avg. Volume950,915
Market Cap8.479B
Beta (5Y Monthly)0.90
PE Ratio (TTM)10.69
EPS (TTM)1.33
Earnings DateN/A
Forward Dividend & Yield0.71 (5.05%)
Ex-Dividend DateMay 13, 2022
1y Target Est27.77
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
25% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for FMS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Fresenius Medical Care AG
    Analyst Report: Fresenius Medical Care AG & Co. KGaAFresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of September 2021. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
    Fair Value
    Economic Moat
    2 months agoMorningstar
View more
  • PR Newswire

    Fresenius Kidney Care Celebrates Nephrology Nurses Week with The CARE Award

    Fresenius Kidney Care, the nation's leading provider of kidney care services, is pleased to announce its new annual recognition program to honor frontline nephrology care team members for embodying the company's core values of collaboration, proactivity, reliability, and excellence in care. Fresenius Kidney Care will present The Caring About Renal Excellence (CARE) Award to those who excel in any of the five clinical pillars: quality and safety, growth, clinical leadership, clinical excellence,

  • Business Wire

    Fresenius Medical Care partners with National Kidney Foundation Malaysia in kidney health initiative

    HONG KONG, September 07, 2022--Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, today signed a memorandum of understanding (MoU) with the National Kidney Foundation (NKF) Malaysia, to work together in promoting kidney health and the prevention of chronic kidney disease amongst children and their families in Malaysia. The organizations will leverage Fresenius Medical Care’s international Corporate Social Responsibility (CSR) initia

  • PR Newswire

    Fresenius Medical Care Wins Major Award to Support U.S. Veterans with Industry-Leading Dialysis Care

    Fresenius Medical North America's (FMCNA) Renal Therapies Group, the leading provider of kidney care products, will be a company of choice to help treat the more than 35,000 military veterans receiving dialysis from the U.S. Department of Veterans Affairs (VA). The VA awarded a five-year contract to FMCNA in five different categories, the most of any medical device company, including home dialysis machines, critical care equipment, water purification systems, and in-center hemodialysis.